$CUE news
The latest CUE stock news: headlines, filings, AI summaries and sentiment for $CUE, updated around the clock.
- Cue Biopharma Shares Drop Over 30% Following Disappointing Phase 2 Trial Results for Chronic Spontaneous Urticaria Treatment
- Cue Biopharma, Inc. - 8-K Filing
- Cue Biopharma Shares Rise Sharply in Premarket Trading After Positive Phase 2 Trial Results
- Cue Biopharma, Inc. - 8-K Filing
- Cue Biopharma, Inc. - 8-K Filing
- Cue Biopharma, Inc. - 8-K Filing
- Cue Biopharma Appoints Lucinda Warren as Interim President and CEO